Diabetic Shoes Market is expected to grow at 6.4% CAGR during the forecast period of 2022-2032

Diabetic footwear with distinct vital components such as raw material and comfort are becoming increasingly popular among diabetes patients worldwide.

They help to reduce the risk of skin damage in diabetic patients with pre-existing diet issues.

The global diabetic footwear market is expected to grow at 6.4% CAGR during the forecast period of 2022-2032, opines Future Market Insights (FMI).

The overall demand in the market is driven by increased innovation by major players to offer personalized and attractive diabetic footwear to meet the latest fashion trends, particularly among the female population.

The quality of life of diabetic patients have improved dramatically when they use diabetic shoes on a regular basis.

Adoption of these shoes is also increasing as they are cost-effective with professional care services such as diabetic foot ulcer treatment and amputations.

This aspect is expected to boost the diabetic shoes sales in the coming years. Further, increased demand for unique designs and comfort will benefit the global diabetic shoe market.

Growing awareness for health and easy availability is expected to improve the demand for diabetic shoes.

Additionally, market participants are providing more tailored diabetic shoes as a result of growing awareness among diabetes patients.

Wellness Diabetes, for instance, offers high-quality footwear made of micro cellular polymer that is personalized for patients with calluses, corns, or other foot deformities.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1191

On the back of these aforementioned factors, the global diabetic shoes market is estimated to surpass US$ 14.9 Bn by the end of 2032.

Key Takeaways

• Dress shoes are predicted to account for the majority of the market in terms of type owing to the increased awareness regarding living a healthy and active lifestyle.
• In terms of width, the medium width segment is held a significant share of 29.5% in 2021.
• Based on end user, women are predicted to hold a considerable proportion of the end-user market due to the increased prevalence of diabetes among women
• Based on patient type, the outpatient category is expected to grow rapidly with a CAGR of 8.3% during the projection period.
• The U.S. held a noteworthy value share of 67.6% in North America in 2021 owing to the rising prevalence of diabetes in the country.

 Who is winning?

Leading manufacturers of diabetic shoes are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of diabetic shoes globally.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1191 

Major players present in the diabetic shoes market are Daifuku, DJO, LLC (Dr. Comfort), Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, ASICS Corporation, Advance Diabetic Solution, Dr Zen Products, Inc., Sensoria Health among others.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global diabetic shoes market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the diabetic shoes market based on the product type (dress shoes, running shoes, strolling shoes, others) patient type (outpatient & inpatient) end user (men & women) width (narrow, medium, wide and others) and sales channel (direct sales, footwear specialty stores, medical & healthcare centres, online retailers, mono-brand stores & other sales channel) across seven major regions